ABSTRACT The effect of lead in vitro on the pH-activity relationship of human erythrocytic 8-aminolaevulinic acid dehydratase (8-ALAD) and on the assessment of lead exposure with ratios of 8-ALAD activity measured at specific pH values was investigated. The addition of lead nitrate to whole blood at concentrations ranging from 0-40 to 8-1 ,umole Pb2+/I, for periods of contact ranging from 16 h to 20 days at 4°C, resulted in a time and dose dependent shift of the enzyme's pH optimum to a more acid value. The pH optimum shift obtained at raised lead concentrations or after long periods of contact at 4°C, in both, closely approximated that observed in vivo. The loss of enzyme activity, however, was significantly less in vitro than that in vivo for similar whole blood lead concentrations. These findings indicate that the presence of trace amounts of lead in blood collection devices can seriously affect results obtained with the pH activity ratio method of assessing lead exposure.
A small increase in an individual's endogenous blood lead concentration may result in a measurable reduction in the activity of the erythrocytic enzyme 8-aminolaevulinic acid dehydratase (8-ALAD, prophobilinogen synthase, EC 42124) assayed at pH 6-4 in phosphate buffer.' The degree of inhibition observed correlates closely with the concomitant concentration of lead in blood and, as such, has been proposed by many as a basis for biologically monitoring exposure to low lead concentrations. '-5 Nikkanen et al have shown that lead has another less apparent effect on the enzyme in vivo.' That is, the enzyme' s pH optimum shifts to more acid values as lead concentrations exceed normal values. This effect has been confirmed by Tomokuni6 and ourselves.7
According to the few studies conducted to date,'8 the action of lead in vitro on the enzyme in human blood does not cause a shift in the pH optimum; Instead, enzyme activity decreases uniformly across the pH range. Nikkanen explained this occurrence by proposing that lead produces its effects in vivo via * Louis, MO) (0.125 mM), and phosphate buffers (0.3M) pH 5-8 to 7-4, preincubated at 37°C for 30 min. The mixtures were capped, vortexed, and the micro tubes placed in a water bath at 37°C for 60 min. The remainder of the assay was performed as described elsewhere."
A pH-activity curve was obtained for b-ALAD at each blood lead concentration and for each corresponding control blood sample after 16 h, 2, 4, 7, 10, 14, and 20 days of storage at 4°C.
It should be noted that one set of samples was fractionnated into plasma and erythrocytes after 1 h of contact with added lead at 4°C. The erythrocytes were washed repeatedly with ice cold saline and stored at 4°C for nine days before the derivation of the 8-ALAD pH activity curve for each sample to determine if plasma borne lead had a role in the 407 effects observed.
8-ALAD ACTIVITY RATIO TESTS
Recently, we have proposed a novel biological test for lead intoxication which involves the measurement of erythrocytic 8-ALAD activity at two carefully selected pH values and the use of the ratio of the activity values obtained as an index of lead exposure.9 In our laboratory this test has proved to be a plausible alternative to the usual tests for lead intoxication-namely, blood lead concentration and free erythrocytic protoporphyrin level. The effect of exogenous lead present in trace amounts in blood collecting devices on one such 8-ALAD activity ratio-namely, 8-ALAD activity measured at pH 6-4 8-ALAD activity measured at pH 7-2 was studied. The enzyme activity values at pH and 7-2 were obtained for each test sample during the derivation of 8-ALAD pH activity curves described above.
BLOOD LEAD ANALYSIS
The analysis of the lead in each blood, plasma, or erythrocytic cytosol sample was performed as described elsewhere." The erythrocytic membrane was separated from the cytosol by centrifugation of the haemolysates at 11 500 rpm for 30 min before analysis.
The la) . As storage time increases, a pH optimum shift to pH 6-0 and a change in the overall shape of the profile analogous to that observed for in vivo lead (fig 2) takes place at ever lower concentrations of adventitious metal (fig lb) . The optimum shift and overall profile shape usually observed in the blood of lead intoxicated individuals (fig 2) are approximated at all concentrations of exogenous lead after 20 days of contact at 4°C (fig lb) . It is noteworthy that an apparent increase in activity occurs at pH 6-0 at all concentrations after 16 h of contact. The relation between blood lead concentrations and enzyme activity measured at pH 6-0, 6-4, and 6-8 (arbitrarily selected) is best depicted in figs 3 and 4 for in vivo and in vitro lead respectively. For in vivo lead, a rather rapid decrease in enzyme activity at blood lead concentrations > 0-8 ,uM Pb/l followed by a tendency to plateau at >3-0 ,M Pb/l takes place at pH 6-4 and 6-8. A more gradual and less pronounced decrease in enzyme activity with increasing blood lead concentrations occurs at pH 6-0. In vitro lead approximates the relationship between residual enzyme activity and blood lead "in vivo" only after relatively long periods of contact at 4°C (fig 4) . Data The fact that such a long time is required for maximum of contact is caused in large part by erythrocyte borne lead. Ninety per cent of erythrocyte borne lead is reportedly bound to the haemoglobin molecule'6 and a portion of the remaining lead probably interacts with the less abundant 8-ALAD. On the basis of findings by Barnard et al, 19 it may be postulated that this lead interacts most readily with the enzyme's active site geminal thiol groups and produces the rapid loss of activity observed both in vivo and in vitro. The results presented here notwithstanding, it is not yet apparent whether this interaction or other similar metal-protein interaction is also responsible for the pH optimum shift observed early in vivo and 1 5 approximated much later in vitro. Evidently, further work is required to find an explanation for both the delayed in vitro effect and the occurrence of the pH optimum shift.
The results presented here would indicate that utmost care must be taken to ensure that blood collection devices are lead free since the adventitious metal will eventually lead to results which approximate those obtained in vivo with the pH activity ratio method of assessing lead exposure. The impact on results obtained with the usual 8-ALAD assay" will be correspondingly less since this determination is usually performed within 24 h of blood sample collection.
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